Ryan Allway June 10th, 2022 News, Top News /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES/ TORONTO, June 10, 2022 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or, the “Company“) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), is pleased to announce that it has closed today its previously announced underwritten overnight public offering... Read more
Pressure BioSciences, Inc. Discusses Commercialization of Their Revolutionary UST Platform and Their Planned 2022 Uplisting with The Stock Day Podcast
CBD April 21, 2022
Ryan Allway April 21st, 2022 News, Top News Phoenix, Arizona–(Newsfile Corp. – April 20, 2022) – The Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or “the Company”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services for... Read more
Ryan Allway January 13th, 2022 VERNON, BC, Jan. 13, 2022 /CNW/ – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”) announces the appointment of Maryam Marissen as Chief Executive Officer and Director, effective immediately. Outgoing interim CEO and co-founder Daniel Vice will remain involved with the Company as an independent director. Doseology is a British Columbia-based, diversified... Read more
FSD Pharma Announces Share Repurchase Program
December 30, 2021
Ryan Allway December 30th, 2021 TORONTO, December 30, 2021–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that its Board of Directors has authorized the repurchase... Read more
